Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.
about
Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical TrialsEffectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients.Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study.HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia.
P2860
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Four years data of raltegravir ...... d patients: the SALIR-E Study.
@ast
Four years data of raltegravir ...... d patients: the SALIR-E Study.
@en
type
label
Four years data of raltegravir ...... d patients: the SALIR-E Study.
@ast
Four years data of raltegravir ...... d patients: the SALIR-E Study.
@en
prefLabel
Four years data of raltegravir ...... d patients: the SALIR-E Study.
@ast
Four years data of raltegravir ...... d patients: the SALIR-E Study.
@en
P2093
P50
P1476
Four years data of raltegravir ...... ed patients: the SALIR-E Study
@en
P2093
Amedeo Capetti
Barbara Menzaghi
Benedetto Maurizio Celesia
Elena Mazzotta
Gaetana Sterrantino
Giovanni Pellicanò
Giuliano Rizzardini
Laura Carenzi
Lolita Sasset
Marco Franzetti
P304
P356
10.1016/J.IJANTIMICAG.2013.10.013
P50
P577
2013-11-15T00:00:00Z